stockrowPerspective Therapeutics, Inc. (CATX) vs Lucid Diagnostics Inc. (LUCD)
- Perspective Therapeutics, Inc. CATX 0.86 +8.86%
- Lucid Diagnostics Inc. LUCD 0.40 +2.56%
Perspective Therapeutics, Inc. and Lucid Diagnostics Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. is the larger, with a market value of $90.0M against $79.3M — 1.1× the size. Lucid Diagnostics Inc. grew revenue faster over the last twelve months: 24.9% against −66.9%. Lucid Diagnostics Inc. has the higher net margin (−1,193.9% vs −28,468.0%) and the lower return on invested capital (−3,096.5% vs −88.4%). Across the 17 metrics below, Lucid Diagnostics Inc. leads on 10 and Perspective Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | CATX | LUCD | Medical Devices median |
|---|---|---|---|
| Gross margin | 100.00% | (21.69%) | 57.76% |
| Operating margin | (30,619.07%) | (930.84%) | (15.07%) |
| Net margin | (28,467.97%) | (1,193.87%) | (14.45%) |
| Free cash flow margin | (29,630.07%) | (866.56%) | (3.88%) |
| Return on equity | (39.50%) | 364.89% | (10.35%) |
| Return on assets | (33.14%) | (167.51%) | (17.26%) |
| Return on invested capital | (88.41%) | (3,096.53%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack